UNLOXCYT 300 mg/5mL
cosibelimab · INJECTION, SOLUTION · Sun Pharmaceutical Industries, Inc.
UNLOXCYT is a injection, solution containing cosibelimab at 300 mg/5mL, taken intravenous. Manufactured by Sun Pharmaceutical Industries, Inc..
Key Facts
- Brand Name
- UNLOXCYT
- Generic Name
- cosibelimab
- NDC Code (Product)
70095-130- Manufacturer
- Sun Pharmaceutical Industries, Inc.
- Strength
- 300 mg/5mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761297
- Drug Class
- Programmed Death Ligand-1 Blocker [EPC]
- Marketing Start
- 12/08/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is UNLOXCYT used for?
UNLOXCYT contains cosibelimab. It is a injection, solution taken intravenous. Consult your doctor for specific uses.
Is UNLOXCYT a controlled substance?
UNLOXCYT is not classified as a controlled substance by the DEA.
What is the generic name for UNLOXCYT?
The generic name for UNLOXCYT is cosibelimab. There are no other listed brand versions of cosibelimab.
What is the NDC code for UNLOXCYT 300 mg/5mL?
The NDC (National Drug Code) for UNLOXCYT 300 mg/5mL is 70095-130, listed by Sun Pharmaceutical Industries, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)